NSIS-B.CO vs. HLUN-B.CO

Last updated Jun 5, 2026

NSIS-B.CO (Novozymes A/S) and HLUN-B.CO (H Lundbeck A/S) are both stocks. NSIS-B.CO operates in Specialty Chemicals (Basic Materials), while HLUN-B.CO operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, NSIS-B.CO returned 3.03%/yr vs -0.39%/yr for HLUN-B.CO. At a 0.21 correlation, their price movements are largely independent.

Performance

NSIS-B.CO vs. HLUN-B.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a DKK 10,000 investment in Novozymes A/S (NSIS-B.CO) and H Lundbeck A/S (HLUN-B.CO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NSIS-B.CO achieves a -8.88% return, which is significantly lower than HLUN-B.CO's 7.04% return. Over the past 10 years, NSIS-B.CO has outperformed HLUN-B.CO with an annualized return of 3.03%, while HLUN-B.CO has yielded a comparatively lower -0.39% annualized return.

NSIS-B.CO

• 1D: 0.22%
• 1M: -5.41%
• YTD: -8.88%
• 6M: -8.00%
• 1Y: -20.86%
• 3Y*: 4.19%
• 5Y*: -2.35%
• 10Y*: 3.03%

HLUN-B.CO

• 1D: 1.36%
• 1M: 5.26%
• YTD: 7.04%
• 6M: 3.17%
• 1Y: 24.93%
• 3Y*: 9.36%
• 5Y*: 5.28%
• 10Y*: -0.39%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NSIS-B.CO vs. HLUN-B.CO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NSIS-B.CO Novozymes A/S	-8.88%	1.60%	10.91%	8.90%	-33.63%	55.73%	8.80%	13.95%	-16.77%	47.75%
HLUN-B.CO H Lundbeck A/S	7.04%	7.11%	28.84%	28.12%	-22.04%	-19.13%	-17.92%	-10.86%	-9.40%	9.64%

Correlation

The correlation between NSIS-B.CO and HLUN-B.CO is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.17
Correlation (10Y) Calculated over the trailing 10-year period	0.21
Correlation (All Time) Calculated using the full available price history since Nov 21, 2000	0.21

Return for Risk

NSIS-B.CO vs. HLUN-B.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NSIS-B.CO

NSIS-B.CO Risk / Return Rank: 11
NSIS-B.CO Sharpe Ratio Rank: 7
NSIS-B.CO Sortino Ratio Rank: 9
NSIS-B.CO Omega Ratio Rank: 11
NSIS-B.CO Calmar Ratio Rank: 15
NSIS-B.CO Martin Ratio Rank: 15

HLUN-B.CO

HLUN-B.CO Risk / Return Rank: 64
HLUN-B.CO Sharpe Ratio Rank: 69
HLUN-B.CO Sortino Ratio Rank: 61
HLUN-B.CO Omega Ratio Rank: 63
HLUN-B.CO Calmar Ratio Rank: 64
HLUN-B.CO Martin Ratio Rank: 63

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NSIS-B.CO vs. HLUN-B.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novozymes A/S (NSIS-B.CO) and H Lundbeck A/S (HLUN-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NSIS-B.CO	HLUN-B.CO	Difference
Sharpe ratio: Return per unit of total volatility	-0.89	0.86	-1.75
Sortino ratio: Return per unit of downside risk	-1.23	1.30	-2.53
Omega ratio: Gain probability vs. loss probability	0.86	1.18	-0.32
Calmar ratio: Return relative to maximum drawdown	-0.72	1.16	-1.88
Martin ratio: Return relative to average drawdown	-1.19	2.50	-3.69
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NSIS-B.CO vs. HLUN-B.CO - Sharpe Ratio Comparison

The current NSIS-B.CO Sharpe Ratio is -0.89, which is lower than the HLUN-B.CO Sharpe Ratio of 0.86. The chart below compares the historical Sharpe Ratios of NSIS-B.CO and HLUN-B.CO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NSIS-B.CO	HLUN-B.CO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.89	0.86	-1.75
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.09	0.18	-0.27
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.12	-0.01	+0.13
Sharpe Ratio (All Time) Calculated using the full available price history	0.41	0.18	+0.23

Drawdowns

NSIS-B.CO vs. HLUN-B.CO - Drawdown Comparison

The maximum NSIS-B.CO drawdown since its inception was -52.31%, smaller than the maximum HLUN-B.CO drawdown of -74.26%. Use the drawdown chart below to compare losses from any high point for NSIS-B.CO and HLUN-B.CO.

Drawdown Indicators

	NSIS-B.CO	HLUN-B.CO	Difference
Max Drawdown Largest peak-to-trough decline	-52.31%	-74.26%	+21.95%
Max Drawdown (1Y) Largest decline over 1 year	-29.44%	-21.88%	-7.56%
Max Drawdown (3Y) Largest decline over 3 years	-29.44%	-42.85%	+13.41%
Max Drawdown (5Y) Largest decline over 5 years	-46.90%	-42.85%	-4.05%
Max Drawdown (10Y) Largest decline over 10 years	-46.90%	-74.26%	+27.36%
Current Drawdown Current decline from peak	-25.78%	-47.65%	+21.87%
Average Drawdown Average peak-to-trough decline	-13.51%	-47.15%	+33.64%
Ulcer Index Depth and duration of drawdowns from previous peaks	17.62%	10.09%	+7.53%

Volatility

NSIS-B.CO vs. HLUN-B.CO - Volatility Comparison

Novozymes A/S (NSIS-B.CO) and H Lundbeck A/S (HLUN-B.CO) have volatilities of 6.88% and 6.72%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NSIS-B.CO	HLUN-B.CO	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.88%	6.72%	+0.16%
Volatility (6M) Calculated over the trailing 6-month period	17.10%	20.96%	-3.86%
Volatility (1Y) Calculated over the trailing 1-year period	23.96%	29.50%	-5.54%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.31%	29.78%	-3.47%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.61%	32.23%	-6.62%

Dividends

NSIS-B.CO vs. HLUN-B.CO - Dividend Comparison

NSIS-B.CO's dividend yield for the trailing twelve months is around 1.77%, less than HLUN-B.CO's 2.57% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HLUN-B.CO H Lundbeck A/S	2.57%	2.20%	1.69%	1.77%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NSIS-B.CO Novozymes A/S	1.77%	1.58%	0.98%	2.75%	1.56%	0.98%	1.50%	1.53%	1.55%	1.13%	1.44%	0.91%

Financials

Frequently Asked Questions

Can I hold both NSIS-B.CO and HLUN-B.CO in my portfolio?

NSIS-B.CO and HLUN-B.CO have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.